YO-01027

CAS No. 209984-56-5

YO-01027 ( Dibenzazepine )

Catalog No. M13326 CAS No. 209984-56-5

YO-01027 (Dibenzazepine) is a dipeptidic γ-secretase inhibitor with IC50 of 2.6 nM and 2.9 nM for APPL and Notch cleavage, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 64 In Stock
5MG 62 In Stock
10MG 106 In Stock
25MG 227 In Stock
50MG 368 In Stock
100MG 591 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    YO-01027
  • Note
    Research use only, not for human use.
  • Brief Description
    YO-01027 (Dibenzazepine) is a dipeptidic γ-secretase inhibitor with IC50 of 2.6 nM and 2.9 nM for APPL and Notch cleavage, respectively.
  • Description
    YO-01027 (Dibenzazepine) is a dipeptidic γ-secretase inhibitor with IC50 of 2.6 nM and 2.9 nM for APPL and Notch cleavage, respectively.
  • In Vitro
    YO-01027 (0.25-10 μM, during 1-18 days) promotes iPSC generation from human neonatal keratinocytes.YO-01027 (2 μM, 3 days) does not affect p53 activity in OCT4, SOX2-transduced human keratinocytes.YO-01027 (10 μM, 3 days) promotes the proliferation of supporting cells (SCs) in cultured mouse cochleae.YO-01027 (10 μM, 3 days) generates new hair cell (HCs) and increases the HCs number in neonatal mouse cochleae.
  • In Vivo
    ——
  • Synonyms
    Dibenzazepine
  • Pathway
    Neuroscience
  • Target
    Gamma-secretase
  • Recptor
    γ secretase (APPL)| γ secretase(Notch)
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    209984-56-5
  • Formula Weight
    463.48
  • Molecular Formula
    C26H23F2N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:92 mg/mL (198.49 mM); Ethanol:<1 mg/mL (<1 mM); Water:<1 mg/mL (<1 mM)
  • SMILES
    C[C@H](NC(CC1=CC(F)=CC(F)=C1)=O)C(N[C@@H]2C(N(C)C3=CC=CC=C3C4=CC=CC=C24)=O)=O
  • Chemical Name
    (S)-2-(2-(3,5-difluorophenyl)acetamido)-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Groth C, et al, Mol Pharmacol, 2010, 77(4), 567-574.
molnova catalog
related products
  • Enoticumab

    Enoticumab (REGN421) is a fully human IgG1 monoclonal antibody with anticancer activity that inhibits the growth of cancer cells.Enoticumab binds human Dll4 and disrupts Notch-mediated signaling.

  • Rovalpituzumab

    Rovalpituzumab is a humanized monoclonal antibody targeting delta-like protein 3 (DLL3) and is utilized to synthesize antibody-active molecule conjugates (ADCs).

  • Brontictuzumab

    Brontictuzumab (OMP 52M5) is a monoclonal antibody that targets Notch1 and inhibits activation of the pathway.